Infusion Set Replacement Intervals for Critically Ill Patients

NCT05359601 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1240

Last updated 2023-12-29

No results posted yet for this study

Summary

This study aimed to evaluate the efficacy of 24-hour versus 96-hour infusion set replacement to prevent central line-associated bloodstream infection (CLABSI) in critically ill adults with central venous access devices.

Conditions

  • Critical Illness

Interventions

PROCEDURE

Infusion set replacement intervals

24-hour or 96-hour infusion set replacement intervals

Sponsors & Collaborators

  • Zhongnan Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-15
Primary Completion
2025-12-30
Completion
2026-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05359601 on ClinicalTrials.gov